CoChat

18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers

Open access
Palaskas, Nicolaos, Larson, Steven M., Schultz, Nikolaus, Komisopoulou, Evangelia, Wong, Justin, Rohle, Dan, Campos, Carl, Yannuzzi, Nicolas, Osborne, Joseph R., Linkov, Irina, Kastenhuber, Edward R., Taschereau, Richard, Plaisier, Seema B., Tran, Chris, Heguy, Adriana, Wu, Hong, Sander, Chris, Phelps, Michael E., Brennan, Cameron, Port, Elisa, Huse, Jason T., Graeber, Thomas G., Mellinghoff, Ingo K. · 2011 · Cancer Research
Cited by 121

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

In contrast to normal cells, cancer cells avidly take up glucose and metabolize it to lactate even when oxygen is abundant, a phenomenon referred to as the Warburg effect. This fundamental alteration in glucose metabolism in cancer cells enables their specific detection by positron emission tomography (PET) following i.v. injection of the glucose analogue 18F-fluorodeoxy-glucose (18FDG). However, this useful imaging technique is limited by the fact that not all cancers avidly take up FDG. To identify molecular determinants of 18FDG retention, we interrogated the transcriptomes of human-cancer cell lines and primary tumors for metabolic pathways associated with 18FDG radiotracer uptake. From ninety-five metabolic pathways that were interrogated, the glycolysis, and several glycolysis-related pathways (pentose phosphate, carbon fixation, aminoacyl-tRNA biosynthesis, one-carbon-pool by folate) showed the greatest transcriptional enrichment. This “FDG signature” predicted FDG uptake in breast cancer cell lines and overlapped with established gene expression signatures for the “basal-like” breast cancer subtype and MYC-induced tumorigenesis in mice. Human breast cancers with nuclear MYC staining and high RNA expression of MYC target genes showed high 18FDG-PET uptake (P < 0.005). Presence of the FDG signature was similarly associated with MYC gene copy gain, increased MYC transcript levels, and elevated expression of metabolic MYC target genes in a human breast cancer genomic dataset. Together, our findings link clinical observations of glucose uptake with a pathologic and molecular subtype of human breast cancer. Furthermore, they suggest related approaches to derive molecular determinants of radiotracer retention for other PET-imaging probes. Cancer Res; 71(15); 5164–74. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-10-4633

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 121

Metadata

Authors
Palaskas, N., Larson, S. M., Schultz, N., Komisopoulou, E., Wong, J., Rohle, D., Campos, C., Yannuzzi, N., Osborne, J. R., Linkov, I., Kastenhuber, E. R., Taschereau, R., Plaisier, S. B., Tran, C., Heguy, A., Wu, H., Sander, C., Phelps, M. E., Brennan, C., Port, E., Huse, J. T., Graeber, T. G., & Mellinghoff, I. K.
Venue
Cancer Research
Published
2011-07-28
Volume
71
Issue
15
Pages
5164-5174
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2166322560
Cited by
121
References
10
FWCI
3.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers. https://app.cochat.ai/papers/10.1158/0008-5472.can-10-4633
The paper
Palaskas, N., Larson, S. M., Schultz, N., Komisopoulou, E., Wong, J., Rohle, D., Campos, C., Yannuzzi, N., Osborne, J. R., Linkov, I., Kastenhuber, E. R., Taschereau, R., Plaisier, S. B., Tran, C., Heguy, A., Wu, H., Sander, C., Phelps, M. E., Brennan, C., . . . Mellinghoff, I. K. (2011). 18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers. Cancer Research. https://doi.org/10.1158/0008-5472.can-10-4633

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.